Latest stories on VOR
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
TipRanks58 · neutralproduct/pr
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News
StockTitan53 · neutralgeneral
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference | VOR Stock News
StockTitan50 · neutralgeneral